{"id":"W7021062038","doi":"","title":"Nabriva Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights","year":2017,"lang":"en","type":"other","venue":"","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Payment; Work (physics); Financial Audit","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003389001,0.0004369067,0.0005253258,0.0001282317,0.0002849921,0.00007363889,0.0002349466,0.001303589,0.007166286],"category_scores_gemma":[0.00008477759,0.0003528352,0.000101683,0.00005208332,0.0003477806,0.00007024375,0.0001073091,0.000921585,0.0001888297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000470524,"about_ca_system_score_gemma":0.0001660746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007073721,"about_ca_topic_score_gemma":0.000596974,"domain_scores_codex":[0.9982024,0.0001064599,0.0004479109,0.0006729269,0.0001488604,0.0004214308],"domain_scores_gemma":[0.9977159,0.0001219721,0.001116624,0.0007064218,0.00008437399,0.0002547296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001817253,0.0001302311,0.00006438038,0.00004539679,0.0001915194,0.000292646,0.00005125777,8.729128e-8,0.002775346,0.0003229401,0.9848148,0.01112967],"study_design_scores_gemma":[0.001040509,0.00007746446,0.0002082337,0.00006187546,0.0001820245,0.0001561319,0.000005265988,0.0000120451,0.006665349,0.000661657,0.9904742,0.0004551987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.001558544,0.002519786,0.00001153265,0.00188592,0.003716705,0.0005574392,0.0003415128,0.0001982162,0.9892104],"genre_scores_gemma":[0.004057341,0.01430554,0.0001638126,0.001691955,0.001213298,0.00003833988,0.0002053641,0.0001546413,0.9781697],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01178575,"threshold_uncertainty_score":0.9999929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1381170495177368,"score_gpt":0.4023041556263717,"score_spread":0.2641871061086349,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}